Novotech said that Siebel Clinical Trial Management System met the organisation’s present needs, and is built on open standards allowing the company to integrate other business applications, such
Under the agreement, Institute of Microbiology has agreed to manufacture natural source interferon products using A5 Labs’ proprietary production technology. Subsequently, A5 Labs plans to submit the products
BMS posted a net income of $949m for the third quarter 2010, or $0.55 per diluted share, compared to net income of $966m, or $0.45 per diluted share,
Biogen Idec has posted a net income of $112.18m for the third quarter 2010, or $1.05 per diluted share, compared to net income of $279.6m, or $0.95 per
The Therasis Filter utilises a systems biology approach to characterise compound mechanism of action, compound-specific biomarkers for clinical development, and synergistic combinations for combination therapy through the construction
Pegasys, under the trade names Pegasys SC 90mg and Pegasys SC 180mg (peginterferon alfa-2a) (hereafter Pegasys) and Copegus, under the trade name Copegus 200mg tablets (ribavirin) are currently
According to papers filed in federal court in Boston, the products were mis-identified as a result of product mix-up. The medicines included the antidepressant Paxil CR and the
McKesson posted a net income of $327m for the second quarter 2010, or $1.25 per diluted share, compared to $301m, or $1.11 per diluted share, for the comparable
SOHM said that the branded products, many of the first-line therapies, will lose patent protection over the next 5 years in the US and present significant opportunities for
The agreement will provide biopharmaceutical companies access to large patient populations and a group of investigators who can manage clinical trials in accordance with ICH/GCP guidelines, considerations for
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.